Expert Opinion on Pharmacotherapy

Papers
(The H4-Index of Expert Opinion on Pharmacotherapy is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Pneumocystis jirovecii: a review with a focus on prevention and treatment52
Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases31
Can NSAIDs and Acetaminophen Effectively Replace Opioid Treatment Options for Acute Pain?31
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection30
Are 5-HT1 receptor agonists effective anti-migraine drugs?28
An update on direct antiviral agents for the treatment of hepatitis C28
New anti-seizure medication for elderly epilepsy patients - a critical narrative review27
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies24
Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options23
Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders23
AVP-786 as a promising treatment option for Alzheimer’s Disease including agitation22
Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance22
Current pharmacotherapy of cryptosporidiosis: an update of the state-of-the-art22
An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease21
Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout21
GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy21
How urgent is the need for new antifungals?20
An evaluation of avatrombopag for the treatment of thrombocytopenia20
The role of sulfonylureas in the treatment of type 2 diabetes20
Are thiazolidinediones a preferred drug treatment for type 2 diabetes?19
Advances with androgen deprivation therapy for prostate cancer19
1.0891849994659